Open AccessLong-Term Impact of Highly Active Antiretroviral Therapy on HIV-Related Health Care Costs
Author(s) -
Philip Keiser,
Naiel Nassar,
Mary Beth Kvanli,
Dianna Turner,
James W. Smith,
Daniel J. Skiest
Publication year - 2001
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/00126334-200105010-00003
Subject(s) - medicine , viral load , emergency medicine , emergency department , veterans affairs , antiretroviral therapy , antiretroviral treatment , human immunodeficiency virus (hiv) , pediatrics , immunology , psychiatry
Highly active antiretroviral therapy (HAART) is associated with decreased opportunistic infections, hospitalization, and HIV-related health care costs over relatively short periods of time. We have previously demonstrated that decreases in total HIV cost are proportional to penetration of protease inhibitor therapy in our clinic.